Indications and clinical use :

(besifloxacin ophthalmic suspension) 0.6%, is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria: 
Aerococcus viridans* -CDC coryneform group G Corynebacterium-pseudodiphtheriticum* Corynebacterium striatum* Haemophilus influenzae 
Moraxella catarrhalis* Moraxella lacunata* Pseudomonas aeruginosa* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus hominis* Staphylococcus lugdunensis* Staphylococcus warneri* Streptococcus mitis group Streptococcus oralis Streptococcus pneumoniae Streptococcus salivarius* 
*Efficacy for this organism was studied in fewer than 10 infections.